KB004

· Humanigen, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KB004, covering 2015-11-17 to 2015-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF) [Phase 1, Phase 2]

See pricing